pathology research of secondary osteoporosis in adult patients with type 1 diabetes mellitus: bone microarchitecture assessed by HR-pQCT

pathology research of secondary osteoporosis in adult patients with type 1 diabetes mellitus: bone microarchitecture assessed by HR-pQCT - T1DM HR-pQCT study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031946

Enrollment

100

Registered

2018-06-01

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type1 diabete mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.adult patients of 20 years and over with type1 diabetes mellitus 2.healthy control each 50 cases

Exclusion criteria

Exclusion criteria: 1.a patient with type2 diabetes mellitus 2.a patient who takes current or past treatment for osteoporosis such as teriparatide, bisphosphonates, and anti-RANKL antibody. 3.a patient who takes a drug such as steroid, anticonvulsant, or hormone replacement therapy 4.a patient with a malignat tumor 5.a patient who is pregnant, may be pregnant, or breastfeed 6.a patient whose alchohol consumption over 20g/day 7.a smoker 8.a patient who participates another clinical research within 6 months 9.a patient who is determined as inappropriate as a subject for other reasons by investigator

Design outcomes

Primary

Measure	Time frame
We investigate bone microarchitecture assessed by HR-pQCT in adult patients with type1 diabetes mellitus. And we compare them with healthy subjects.	—

Secondary

Measure	Time frame
We compare the relationship between bone microarchitecture and metabolic markers with healthy subjects.	—

Countries

Japan

Contacts

Public ContactErika Aikawa

Nagasaki University Hospital Department of Endocrinology and Metabolism

erikaaikawa@nagasaki-u.ac.jp095-819-7262

Outcome results